GRANGER, Ind., Dec. 15, 2004 (PRIMEZONE) -- Ken Weiner, Publisher of Shazamstocks.com, today announced profile coverage of GelStat Corporation (OTCBB:GSAC).The profile is a comprehensive look at GelStat Corporation, the company's subsidiaries and products. You can view the complete profile at http://profiles.shaazamstocks.com/gsac/index.htm
About GelStat Corporation
GelStat Corporation is a consumer healthcare company dedicated to the cost-effective development and marketing of advanced OTC health care products. Development efforts are focused on very large markets where GelStat products can offer improved efficacy, safety, and/or convenience over existing OTCs.
The Company has announced plans to introduce "GelStat(tm) Sinus", "GelStat(tm) Arthritis" and "GelStat(tm) Sleep", and believes that each of these products performs well and is effective for its intended use. The National Institute of Allergy and Infectious Disease estimates that 37 million Americans are affected by sinusitis every year. Between 40 and 70 million Americans have some form of arthritis according to the National Institutes of Health. Approximately 70 million Americans are reported to be "problem sleepers".
The Company has also recently announced the formation of a wholly owned subsidiary, "GS Pharma, Inc." to pursue various pharmaceutical (prescription drug) opportunities that are believed to exist relative to the Company's intellectual property and now ongoing research and development work. The direct commercialization and development of these opportunities is believed to be beyond the scope of activity reasonably possible for GelStat Corporation in the foreseeable future. Therefore, in the interest of maximizing shareholder value, the Company is at present investigating several potential opportunities with regard to this subsidiary and what it believes to be prescription pharmaceutical opportunities.
For more information on GelStat Corporation, please visit http://www.GelStat.com
About Shazamstocks.com
Shazamstocks.com publishes profiles on up and coming publicly traded companies. Shazamstocks.com is one of the nation's top Internet destinations for small cap stock information. To feature your company, please call Ken Weiner, our publisher at (574) 273-8755 or email editor@shazamstocks.com.
Disclosure: Shazamstocks.com has been compensated by GelStat Corporation $15,000 and 9,000 rule 144 shares for publication of this profile. Details can be found at http://www.shazamstocks.com
Forward-Looking Statements
Included in this release are certain "forward-looking" statements, involving risks and uncertainties, which are covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the company's financial performance. Such statements are based on management's current expectations and are subject to certain factors, risks and uncertainties that may cause actual results, events and performance to differ materially from those referred to or implied by such statements. In addition, actual future results may differ materially from those anticipated, depending on a variety of factors, sales and earnings growth, ability to attract and retain key personnel, and general economic conditions affecting consumer spending, including uncertainties relating to global political conditions, such as terrorism. Information with respect to important factors that should be considered is contained in the company's Annual Report on Form 10-K as filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.